Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Latest Market Insights for the Onchocerciasis Treatment Industry?

The market size for onchocerciasis treatment has experienced robust growth in the past few years. It is projected to expand from $1.03 billion in 2024 to $1.11 billion in 2025, boasting a compound annual growth rate (CAGR) of 7.8%. The previous growth trajectory can be accounted for by factors such as a rise in cases of eye-related conditions, a surge in parasitic infections, an increase in the quantity of specialized treatment facilities, an escalation in educational outreach efforts, and a growth in the aging population.

The market for onchocerciasis treatment is predicted to significantly expand in the upcoming years, projected to reach $1.48 billion in 2029 with a compound annual growth rate (CAGR) of 7.5%. The expected growth in this period is due to a number of factors including the increased frequency of the disease in endemic regions, a surge in demand for surgical interventions, enhancements in healthcare structures, a rise in the incidence of chronic illnesses and escalating investments in healthcare. Notable trends anticipated within this period encompass a movement towards single-dose treatment plans, progress in macrocyclic lactone formulations, the introduction of Wolbachia-targeting therapies, the implementation of artificial intelligence (AI) in medication discovery, and the evolution of treatments specifically designed for children.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24634&type=smp

What Forces Are Driving The Growth Of The Onchocerciasis Treatment Industry?

The increasing number of individuals dealing with vision problems is expected to influence the growth of the onchocerciasis treatment market in a positive way. Problems related to eyes can range from infections and injuries to chronic illnesses like glaucoma or cataracts. Enhanced screen time and overexposure to digital devices are primary reasons for the surge in cases. Treating onchocerciasis helps in preventing vision loss or blindness in patients by removing the parasitic infection causing inflammation and damage to eye tissues. For example, data from the Centers for Disease Control and Prevention (CDC) reveals that approximately 20.5 million Americans above 40 years have at least one eye affected by cataracts, making up 17.2% of this age group, as of May 2024. Predictions suggest that close to 30 million people may develop cataracts by 2028. Hence, the growing occurrence of eye-related problems largely contributes to the growth of the onchocerciasis treatment market. Expansion In Surgical Measures Leads To Market Growth Due To Escalating Cases Needing Complex Disease Management

What Is The Overview Of Market Segmentation In The Onchocerciasis Treatment Industry?

The onchocerciasis treatment market covered in this report is segmented –

1) By Drug Type: Ivermectin, Doxycycline, Albendazole, Moxidectin

2) By Treatment Strategy: Mass Drug Administration (MDA), Targeted Treatment

3) By Mode Of Administration: Oral, Injectables, Topical

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

5) By End User: Hospitals And Clinics, Home Care Settings, Government And Non-Governmental Programs

Subsegments:

1) By Ivermectin: Oral Tablets, Community-Based Mass Drug Administration (MDA) Kits, Fixed-Dose Combination Therapies, Pediatric Formulations

2) By Doxycycline: Oral Capsules, Extended-Release Tablets, Combination With Anti-Wolbachia Therapy, Hospital-Based Prescription Treatments

3) By Albendazole: Single-Dose Oral Tablets, Combination Therapy With Ivermectin, Government-Supplied Preventive Chemotherapy Packages, Over-The-Counter (OTC) Formulations In Endemic Areas

4) By Moxidectin: Oral Tablets, Long-Acting Formulations, Adult-Only Dosing Regimens, Clinical Trial-Based Access Programs

What Future Market Trends Are Projected For The Onchocerciasis Treatment Industry?

Leading companies in the onchocerciasis treatment market are concentrating their efforts on creating new antiparasitic drugs to increase the effectiveness of treatment and decrease the treatment duration. Antiparasitic drugs are engineered to counter or eradicate parasites that lead to infections in humans, such as worms and protozoa. For example, in December 2024, the Ghana Food and Drugs Authority gave approval to Medicines Development for Global Health (MDGH) – a non-profit biopharmaceutical enterprise located in Australia – for their Moxidectin 2 mg oral tablets. These are designed to treat river blindness in people who are at least 4 years old. As a result of the approval, Ghana has the ability to initiate mass drug administration programs at a community level with moxidectin, a medication that is more effective and has longer-lasting impacts than its counterpart, ivermectin. With the green light from the FDA, MDGH has the goal of increasing the availability of this new, effective treatment for onchocerciasis, which would enable wide-scale community initiatives in regions where the disease is endemic.

Who Are The Primary Players Operating Across The Global Onchocerciasis Treatment Market?

Major companies operating in the onchocerciasis treatment market are Merck & Co. Inc., Teva Pharmaceutical Industries Limited, Hetero Labs Limited, Sun Pharmaceutical Industries Limited, Intas Pharmaceuticals Limited, Dr. Reddy’s Laboratories Inc., Cipla Limited, Endo Inc., Lupin Limited, Instituto de Tecnologia em Imunobiológicos Bio-Manguinhos – Fundação Oswaldo Cruz (Fiocruz), AMGIS Lifescience Ltd., Drugs for Neglected Diseases initiative (DNDi), Rakshit Drugs Pvt. Ltd., Hangzhou Longshine Bio-Tech Co. Ltd., OREX Pharma Private Limited, Angle Bio Pharma Pvt. Ltd., Senores Pharmaceuticals Inc., Avenacy LLC, Dolphin Pharma, Cerata Pharmaceuticals Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/onchocerciasis-treatment-global-market-report

Which Region Offers The Most Growth Potential For The Onchocerciasis Treatment Market Through 2029?

North America was the largest region in the onchocerciasis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the onchocerciasis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24634&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model